Paclitaxel and Fibrin d dimer increased - a phase IV clinical study of FDA data

Summary:

Fibrin d dimer increased is reported as a side effect among people who take Paclitaxel (paclitaxel), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Carboplatin, and have Breast cancer metastatic.

The phase IV clinical study analyzes which people have Fibrin d dimer increased when taking Paclitaxel. It is created by eHealthMe based on reports of 85,850 people who have side effects when taking Paclitaxel from the FDA, and is updated regularly.

What is Paclitaxel?

Paclitaxel has active ingredients of paclitaxel. It is often used in breast cancer. eHealthMe is studying from 85,928 Paclitaxel users. Check the latest studies of Paclitaxel.

What is Fibrin d dimer increased?

Fibrin d dimer increased is found to be associated with 517 drugs and 834 conditions by eHealthMe. Check the latest studies of Fibrin d dimer increased.

On Jul, 15, 2026

85,850 people reported to have side effects when taking Paclitaxel.
Among them, 44 people (0.05%) have Fibrin d dimer increased.

Could Paclitaxel cause Fibrin d dimer increased?

Among these 44 people:

How long have people been on Paclitaxel when they have Fibrin d dimer increased? *

What is the gender of people who have Fibrin d dimer increased when taking Paclitaxel? *

female: 79.07 %
male: 20.93 %

What is the age of people who have Fibrin d dimer increased when taking Paclitaxel? *

What are other drugs people take besides Paclitaxel? *

What are other side effects people have besides Fibrin d dimer increased? *

Dyspnea (difficult or laboured breathing): 18 people, 40.91%
Thrombocytopenia (decrease of platelets in blood): 15 people, 34.09%
Fatigue (feeling of tiredness): 14 people, 31.82%
Malignant Neoplasm Progression (cancer tumour came back): 13 people, 29.55%
Blood Lactate Dehydrogenase Increased: 11 people, 25.00%
General Physical Health Deterioration (weak health status): 11 people, 25.00%
Mucosal Inflammation (infection of mucous membrane): 10 people, 22.73%
Congestive Cardiomyopathy (weakening of heart muscle): 10 people, 22.73%
Breast Cancer Metastatic: 8 people, 18.18%
Fever: 7 people, 15.91%

What are the existing conditions these people have? *

Breast Cancer Metastatic: 10 people, 22.73%
Lung Adenocarcinoma (a form of non-small cell lung cancer): 3 people, 6.82%
Lung Neoplasm Malignant (cancer tumour of lung): 2 people, 4.55%
Embolism Venous (embolus may pass into the arterial system): 2 people, 4.55%
Metastases To Lymph Nodes (cancer spreads to lymph node): 2 people, 4.55%
Ovarian Epithelial Cancer Recurrent (reoccurrence of cancer that begins in the cells on the surface of the ovary): 2 people, 4.55%
Osteoporosis (bones weak and more likely to break): 1 person, 2.27%
Lung Adenocarcinoma Recurrent (reoccurrence of a form of non-small cell lung cancer): 1 person, 2.27%
Endometrial Cancer: 1 person, 2.27%
Gastric Ulcer (stomach ulcer): 1 person, 2.27%

* Approximation only. Some reports may have incomplete information.

Do you take Paclitaxel and have Fibrin d dimer increased?

- Check whether Fibrin d dimer increased is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Paclitaxel:

Paclitaxel (85,928 reports)

Browse all side effects of Paclitaxel:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Fibrin d dimer increased:

Fibrin d dimer increased (517 drugs)

Browse all the conditions that are associated with Fibrin d dimer increased:

Fibrin d dimer increased (834 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on paclitaxel (the active ingredients of Paclitaxel) and Paclitaxel (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.